好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Metastatic Hepatocellular Carcinoma Presenting with Multiple Lower Cranial Nerve Palsies (Collet-Sicard Syndrome)
Neuro-oncology
P06 - (-)
143
BACKGROUND: 62 year-old male with a history of alcoholic cirrhosis presented with three-months history of headache, dysphagia, dysarthria and dysphonia.
DESIGN/METHODS: Initial neurological evaluation for headache was unremarkable. Speech evaluation was suggestive of mild weakness and atrophy of the left tongue with leftward deviation upon protrusion. Re-evaluation in 2 months: - marked left tongue weakness, atrophy and fasciculations; - uvula deviated to right; - weakness of the left trapezius and sternocleidomastoid.
RESULTS: Alpha fetoprotein (AFP): moderately elevated. Initial evaluation with unenhanced brain MRI: non-diagnostic; Repeat MRI brain with contrast: expansile mass in the clivus with extension into the left occipital condyle. Workup for primary malignancy: - CT abdomen/pelvis: mild splenomegaly and a 'subtle hypodense' 3.3 cm mass in the right hepatic lobe. - Abdominal MRI: non-diagnostic; - USG abdomen: 3.3 cm echodense and fairly well marginated mass in right lobe of the liver most likely hemangioma. - Whole body FDG-PET: mild uptake in the skull base without other abnormal activity. Biopsy of clivus mass: moderately well-differentiated hepatocellular carcinoma.
CONCLUSIONS: The patient initially manifested the 'Occipital condyle syndrome' - unilateral headache and ipsilateral tongue weakness. By the time of diagnosis tumor involved multiple lower cranial nerves: 'Collet-Sicard syndrome'- a lesion of cranial nerves IX, X, XI, XII. A recent review identified only 25 reports of HCC metastatic to skull base. Our patient did not have a well-defined primary lesion accessible for biopsy based on extensive imaging studies therefore clivus mass was biopsied and was consistent with HCC. The prognosis is poor, with usual survival less than 9 months.
Authors/Disclosures
Gowri Lakshminarayan, MD
PRESENTER
No disclosure on file
John C. Adair, MD (University of New Mexico) No disclosure on file
No disclosure on file